Patent details
EP2329848 Title: Lixisenatide as add-on therapy to insulin glargine and metformin for treating type 2 diabetes
Basic Information
- Publication number:
- EP2329848
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP091758771
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Lixisenatide as add-on therapy to insulin glargine and metformin for treating type 2 diabetes
- French Title of Invention:
- Lixisénatide en tant que traitement d'appoint à l'insuline glargine et à la metformine dans le diabète de type 2
- German Title of Invention:
- Lixisenatide zusätzlich zu Metformin und Insulin-glargin bei der Behandlung von Typ 2-Diabetes
- SPC Number:
Dates
- Filing date:
- 13/11/2009
- Grant date:
- 24/10/2012
- EP Publication Date:
- 08/06/2011
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/06/2011
- EP B1 Publication Date:
- 24/10/2012
- EP B2 Publication Date:
- 19/06/2019
- EP B3 Publication Date:
- Lapsed date:
- 13/11/2019
- Expiration date:
- 13/11/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/06/2019
- Name:
- Sanofi-Aventis Deutschland GmbH
- Address:
- Brüningstraße 50, 65929 Frankfurt am Main, Germany (DE)
Agent
- Name:
- ARONOVA S.A.
- From:
- 24/01/2013
- Address:
- PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Silvestre, Louise
- Address:
- France (FR)
2
- Name:
- Souhami, Elisabeth
- Address:
- France (FR)
3
- Name:
- Wei, Xiaodan
- Address:
- United States (US)
Classification
- IPC classification:
- A61K 31/155; A61K 38/26; A61K 38/28; A61K 45/06;
Publication
European Patent Bulletin
- Issue number:
- 201925
- Publication date:
- 19/06/2019
- Description:
- Patent maintained (B2 publication)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 24/10/2018
- Last Annual Fee Paid Number:
- 10
- Last Annual Fee Paid Amount:
- 131 Euro
- Payer:
- MARKS & CLERK LLP
| Filing date | Document type | Number of pages |
|---|